Cancer warning on IBS treatment drugs

2014 Research
IBS drugs called thiopurines, cause a 7-fold risk of blood and bone marrow diseases’ like leukaemia and multiple myeloma, according to a study conducted by researchers from the University Hospital of Nancy-Brabois in France and published in the journal Clinical Gastroenterology and Hepatology.

The drugs reduce the inflammatory response in IBS, Crohn’s, colitis and other digestive diseases.

Research followed 19,486 people who were participating in the Cancers Et Surrisque Associe aux Maladies inflammatoires intestinales En France study, which took place between May 2004 and June 2005. Three years later, the researchers followed up to see which patients had been diagnosed with myeloid disorders, including myeloid leukaemia and the bone marrow disorder myelodysplastic syndrome.

In our book ’The Secret Source of your Good Health’ we review all the latest research on gut bacteria. When it comes to IBS, Crohn’s and colitis, research shows that drugs can actually make the illness worse and offer little in the way of benefit. Natural solutions like faecal enemas seem the most likely way to treat and clear symptoms without side-effects.

You can buy the book by following this link: Click here for UK
Click Here for Australia.
2014 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.